123
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

The consistency of aminotransferase analysis in China: a comparison of six mainstream aminotransferase routine methods and recalibration using human pooled serum preparations supplemented with human recombinant aminotransferases

, , , , , , , , , , & show all
Pages 58-67 | Received 31 Mar 2021, Accepted 03 Jan 2022, Published online: 21 Jan 2022

References

  • Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18–35.
  • Goessling W, Massaro JM, Vasan RS, et al. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology. 2008;135(6):1935–1944.
  • Ioannou GN, Weiss NS, Boyko EJ, et al. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology. 2006;43(5):1145–1151.
  • Kain K, Carter AM, Grant PJ, et al. Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population. J Thromb Haemost. 2008;6(5):737–741.
  • Song HR, Yun KE, Park HS. Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women. Am J Clin Nutr. 2008;88(1):16–21.
  • Xie K, Chen CH, Tsai SP, et al. Loss of life expectancy by 10 years or more from elevated aspartate aminotransferase: finding aspartate aminotransferase a better mortality predictor for all-cause and liver-related than alanine aminotransferase. Am J Gastroenterol. 2019;114(9):1478–1487.
  • Schumann G, International Federation of Clinical Chemistry and Laboratory Medicine, Bonora R, Ceriotti F, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International federation of clinical chemistry and laboratory medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. Clin Chem Lab Med. 2002;40(7):718–724.
  • Schumann G, International Federation of Clinical Chemistry and Laboratory Medicine, Bonora R, Ceriotti F, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International federation of clinical chemistry and laboratory medicine. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase. Clin Chem Lab Med. 2002;40(7):725–733.
  • Ono K, Ono T, Matsumata T. The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency. Clin Nephrol. 1995;43(6):405–408.
  • Westerhuis LW, Hafkenscheid JC. Apoenzyme content of serum aminotransferases in relation to plasma pyridoxal-5'-phosphate concentration. Clin Chem. 1983;29(5):789–792.
  • Wang Y, Wang J, Zhao H, et al. Assessment of enzyme measurement procedures in China through a trueness verification program. Clin Chim Acta. 2016;461:98–102.
  • Tong Q, Chen B, Zhang R, et al. Standardization of clinical enzyme analysis using frozen human serum pools with values assigned by the international federation of clinical chemistry and laboratory medicine reference measurement procedures. Scand J Clin Lab Invest. 2018;78(1–2):74–80.
  • Long Q, Qi T, Zhang T, et al. Commutability assessment of candidate external quality assessment materials for aminotransferase activity measurements based on different approaches in China. Ann Lab Med. 2021;41(1):68–76.
  • CLSI. EP09-A3: measurement procedure comparison and bias estimation using patient samples; approved guideline. Wayne (PA): Clinical and Laboratory Standards Institute; 2013.
  • RELA-IFCC External quality control for Reference Laboratories. Available from: http://dgklrfb.de:81/ [Accessed on Feb 2020].
  • Carobene A, European Biological Variation Study of the EFLM Working Group on Biological Variation, Røraas T, Sølvik U, et al. Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum. Clin Chem. 2017;63(6):1141–1150.
  • CLSI. C37-A: preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures, approved guideline. Wayne (PA): Clinical and Laboratory Standards Institute; 1999.
  • CLSI. EP15-A3: user demonstration of performance for precision and trueness; approved guideline. Wayne (PA): Clinical and Laboratory Standards Institute; 2014.
  • Ceriotti F, Fernandez-Calle P, Klee GG, et al. Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM strategic conference. Clin Chem Lab Med. 2017;55(2):189–194.
  • Yin Y, Ma C, Yu S, et al. Comparison of three different chemiluminescence assays and a rapid liquid chromatography tandem mass spectrometry method for measuring serum aldosterone. Clin Chem Lab Med. 2019;58(1):95–102.
  • Cattozzo G, Enzyme Working Group of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC), Guerra E, Ceriotti F, et al. Commutable calibrator with value assigned by the IFCC reference procedure to harmonize serum lactate dehydrogenase activity results measured by 2 different methods. Clin Chem. 2008;54(8):1349–1355.
  • Rami L, Roura M, Canalias F. Evaluation of commutability of several materials for harmonization alkaline phosphatase catalytic concentration measurements. Clin Chim Acta. 2012;413(15–16):1249–1254.
  • Guo Q, Wang J, Yi X, et al. Commutability of reference materials for alkaline phosphatase measurements. Scand J Clin Lab Invest. 2020;80(5):388–394.
  • Eto A, Shiki A, Chikaura Y, et al. Multienzyme control serum (Seraclear-HE) containing human enzymes from established cell lines and other sources. 1: preparation and properties. Clin Chem. 1995;41(6):872–880.
  • Nakano NI, Eto A, Chikaura Y, et al. Multienzyme control serum (Seraclear-HE) containing human enzymes from established cell lines and other sources. 2: evaluation as candidate working enzyme reference material for alanine and aspartate aminotransferases. Clin Chem. 1995;41(6 Pt 1):881–891.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.